These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 25254416

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Population pharmacokinetic modelling and design of a Bayesian estimator for therapeutic drug monitoring of tacrolimus in lung transplantation.
    Monchaud C, de Winter BC, Knoop C, Estenne M, Reynaud-Gaubert M, Pison C, Stern M, Kessler R, Guillemain R, Marquet P, Rousseau A.
    Clin Pharmacokinet; 2012 Mar 01; 51(3):175-86. PubMed ID: 22339449
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation.
    Benkali K, Rostaing L, Premaud A, Woillard JB, Saint-Marcoux F, Urien S, Kamar N, Marquet P, Rousseau A.
    Clin Pharmacokinet; 2010 Oct 01; 49(10):683-92. PubMed ID: 20818834
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?
    Brooks E, Tett SE, Isbel NM, Staatz CE.
    Clin Pharmacokinet; 2016 Nov 01; 55(11):1295-1335. PubMed ID: 27138787
    [Abstract] [Full Text] [Related]

  • 10. Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients.
    Benkali K, Prémaud A, Picard N, Rérolle JP, Toupance O, Hoizey G, Turcant A, Villemain F, Le Meur Y, Marquet P, Rousseau A.
    Clin Pharmacokinet; 2009 Nov 01; 48(12):805-16. PubMed ID: 19902988
    [Abstract] [Full Text] [Related]

  • 11. Population Pharmacokinetics and Bayesian Estimators for Refined Dose Adjustment of a New Tacrolimus Formulation in Kidney and Liver Transplant Patients.
    Woillard JB, Debord J, Monchaud C, Saint-Marcoux F, Marquet P.
    Clin Pharmacokinet; 2017 Dec 01; 56(12):1491-1498. PubMed ID: 28389935
    [Abstract] [Full Text] [Related]

  • 12. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients.
    Staatz CE, Willis C, Taylor PJ, Tett SE.
    Clin Pharmacol Ther; 2002 Dec 01; 72(6):660-9. PubMed ID: 12496747
    [Abstract] [Full Text] [Related]

  • 13. Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation.
    Staatz CE, Willis C, Taylor PJ, Lynch SV, Tett SE.
    Liver Transpl; 2003 Feb 01; 9(2):130-7. PubMed ID: 12548506
    [Abstract] [Full Text] [Related]

  • 14. Population pharmacokinetic-pharmacogenetic model of tacrolimus in the early period after kidney transplantation.
    Han N, Ha S, Yun HY, Kim MG, Min SI, Ha J, Lee JI, Oh JM, Kim IW.
    Basic Clin Pharmacol Toxicol; 2014 May 01; 114(5):400-6. PubMed ID: 24238261
    [Abstract] [Full Text] [Related]

  • 15. Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations--twice daily Prograf and once daily Advagraf.
    Woillard JB, de Winter BC, Kamar N, Marquet P, Rostaing L, Rousseau A.
    Br J Clin Pharmacol; 2011 Mar 01; 71(3):391-402. PubMed ID: 21284698
    [Abstract] [Full Text] [Related]

  • 16. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in Chinese liver transplant patients.
    Chen B, Shi HQ, Liu XX, Zhang WX, Lu JQ, Xu BM, Chen H.
    J Clin Pharm Ther; 2017 Dec 01; 42(6):679-688. PubMed ID: 28833329
    [Abstract] [Full Text] [Related]

  • 17. Population pharmacokinetics of tacrolimus in adult kidney transplant patients: impact of CYP3A5 genotype on starting dose.
    Bergmann TK, Hennig S, Barraclough KA, Isbel NM, Staatz CE.
    Ther Drug Monit; 2014 Feb 01; 36(1):62-70. PubMed ID: 24089074
    [Abstract] [Full Text] [Related]

  • 18. Tacrolimus population pharmacokinetics in adult heart transplant patients.
    Paschier A, Destere A, Monchaud C, Labriffe M, Marquet P, Woillard JB.
    Br J Clin Pharmacol; 2023 Dec 01; 89(12):3584-3595. PubMed ID: 37477064
    [Abstract] [Full Text] [Related]

  • 19. Flexible limited sampling model for monitoring tacrolimus in stable patients having undergone liver transplantation with samples 4 to 6 hours after dosing is superior to trough concentration.
    Langers P, Press RR, den Hartigh J, Cremers SC, Baranski AG, Lamers CB, Hommes DW, van Hoek B.
    Ther Drug Monit; 2008 Aug 01; 30(4):456-61. PubMed ID: 18641539
    [Abstract] [Full Text] [Related]

  • 20. Tacrolimus dose individualization in "de novo" patients after 10 years of experience in liver transplantation: pharmacokinetic considerations and patient pathophysiology.
    Valdivieso N, Oteo I, Valdivieso A, Lukas JC, Leal N, Gastaca M, de Urbina JO, Calvo R, Suarez E.
    Int J Clin Pharmacol Ther; 2013 Jul 01; 51(7):606-14. PubMed ID: 23735178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.